Search results for: cardiovascular disease

Janus Kinase Inhibitors Represent New Tool to Slow Rheumatoid Arthritis

Gretchen Henkel | July 1, 2014

Physicians at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco report on studies about JAK inhibitors as targeted immunomodulators and disease-modifying therapies in RA

Global Perspectives on Managing Rheumatoid Arthritis Addressed at the 2013 ACR/ARHP Annual Meeting

Susan Bernstein | April 2, 2014

Poverty, poor access to healthcare, cultural myths present challenges for rheumatologists caring for patients with RA in developing economic regions

Rheuminations: Why the Obesity Epidemic Should Matter to Rheumatologists

Simon M. Helfgott, MD | January 1, 2014

As changes in diet and eating habits have caused obesity rates to soar, research into the metabolic syndrome suggests obesity may be a form of a low-grade inflammatory state

Genetic Link Between Cellular Cholesterol Homeostasis and Energy Metabolism

Lara C. Pullen, PhD | November 19, 2013

A new study suggests that GATM may serve as the functional link between the ability of statins to lower cholesterol and their ability to cause statin-induced myopathy. (posted Nov. 19)

The Dietitian’s Role in Managing Rheumatology Patients

Sotiria Everett, EdD, RD, CDN, CSSD | November 1, 2013

How dietary experts can help a multidisciplinary healthcare team by educating patients on nutrition and their health

Study Points to Need for Increased Antirheumatic Therapy in Patients with Dyslipidemia

Lara C. Pullen, PhD | October 4, 2013

A new study suggests that patients diagnosed with RA as well as dyslipidemia may benefit from more aggressive antirheumatic therapy. (posted Oct. 3, 2013)

Rheumatology Research Foundation Advances Studies in Inflammatory Arthritis

Staff | October 1, 2013

Disease Targeted Research Initiative may improve treatment, prevention of rheumatoid arthritis, other inflammatory diseases

Letters: The True Challenge of Rheumatology

Marcia S. Genta, MD | September 1, 2013

A physician reflects on an emotional visit with a terminally ill patient

Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?

Theodore Pincus, MD | April 1, 2013

Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)

Letter: There’s No Reason Now to Screen for Uric Acid

Robert H. Shmerling, MD | March 1, 2013

Screening was common in the 1970s and before, but new studies demonstrate that most hyperuricemia patients never developed gout or kidney stones, so enthusiasm for screening waned